Frazer Morgan

Frazer Morgan

Company: Kinaset Therapeutics, Inc

Job title: Chief Development Officer & Co-Founder


Closing Q&A Panel 5:40 pm

Read more

day: Day One

Updates on Non-Oral JAKi Therapy: Unique Challenges & Interest 9:00 am

Outlining current challenges and opportunities with alternative JAKi application Sharing insights from multidisciplinary backgrounds and application experience Speculating on the upcoming therapeutic landscape and potential for alternative JAKi interventionRead more

day: Day Two

Developing inhaled JAKs to Address Unmet Needs in Respiratory Disease 5:15 pm

Detailing the mechanism of action for JAK inhibition in asthma Providing key challenges in inhaled JAK development Describing a KN-002 program overviewRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.